Biotech Firm Announces Appointment of New CFO: Stock Spikes In Volume

Ocean Biomedical Inc. (OCEA) has seen a significant increase in trading volume recently, up by 5.19%. The biotech firm is making waves not just in the stock market but in the biotech industry as well. On March 1st, they appointed a new Chief Financial Officer (CFO), Jolie Kahn, and later this month, their Joint Venture Partner will be presenting clinical data at the prestigious 2024 Global Liver Meeting. $Ocean Biomedical (OCEA.US)$